NDSN NORDSON CORP
Price Chart
Executive Summary
Nordson reported a record second quarter with sales up 8% YoY to $741M and adjusted EPS up 18% to $2.86, exceeding the $2.85 consensus. The company raised full-year guidance for sales ($2,930-$3,010M) and adjusted EPS ($11.30-$11.80), citing broad-based growth across all segments and strong backlog (+18% YoY).
Key Financial Metrics
Actionable Insight
The raised guidance (+3.6% at midpoint for sales, +3.6% for adjusted EPS) and 18% backlog growth signal accelerating end-market demand. With 63% analyst bullish rating and strong first-half momentum, look for continued operational leverage in H2 if tariff/trade headwinds remain contained. The pension settlement charge ($24M non-cash) is a one-time item — monitor Q3 margin trajectory for any reinvestment drag.
Key Facts
- Q2 fiscal 2026 sales were a record $741M, up 8% YoY (7% organic, 3% FX tailwind, -0.8% from medical divestiture)
- Adjusted EPS was a record $2.86, up 18% YoY from $2.42; GAAP EPS was $2.09, including a $0.43 non-cash pension settlement charge and $0.18 non-cash loss on minority investments
- Backlog up 18% YoY entering Q3, with broad-based order momentum
- Full-year fiscal 2026 guidance raised: sales now $2,930-$3,010M (prev. $2,830-$2,950M) and adjusted EPS $11.30-$11.80 (prev. $10.80-$11.50)
- All three segments posted record or best-ever Q2 sales: Industrial Precision Solutions +10%, Medical & Fluid Solutions +5%, Advanced Technology Solutions +10%
- Completed acquisition of CapstanAG Systems (precision agriculture) on March 16, 2026 — small bolt-on
- Free cash flow conversion was 119% in Q2 (excl. pension charge and minority investment non-cash items)
Financial Impact
Raised full-year adjusted EPS guidance by ~$0.40 at midpoint ($11.55 vs. $11.15) on higher revenue outlook; Q2 adjusted EPS beat by $0.01 vs. consensus of $2.85; record sales and EBITDA margins
Risk Factors
- Tariff/trade policy uncertainty and currency volatility could pressure organic growth and margins
- Downside risk to Q3 guidance ($2.95-$3.15) if end-market demand softens or FX turns negative
- Debt paydown remains slow ($107M repaid in H1 vs $224M in FY2025); leverage still elevated at ~2.3x EBITDA
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000072331-26-000022 |
| Document: ndsn-20260520.htm | 0000072331-26-000022 |
| Document: 0000072331-26-000022-index-headers.html | 0000072331-26-000022 |
| Document: 0000072331-26-000022-index.html | 0000072331-26-000022 |
| Document: 0000072331-26-000022.txt | 0000072331-26-000022 |
| 8-K Data (Synthetic) | 0000072331-26-000022 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
6d ago
|
8-K
| $289.04 $286.22 | ▼ −0.98% | ▼ −1.37% | $282.21 (−2.36%) |
|
May 20, 2026
20d ago
|
8-K
| $285.43 $289.87 | ▲ +1.56% | ▲ +1.11% | $282.21 (−1.13%) |
|
Apr 15, 2026
8w ago
|
Insider Cluster
| $273.87 $276.70 | ▲ +1.03% | ▲ +0.78% | $282.21 (+3.04%) |
|
Apr 8, 2026
9w ago
|
Insider Cluster
| $274.37 $276.25 | ▲ +0.68% | ▲ +0.11% | $282.21 (+2.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access